Already on a GLP-1 medication? This monitoring blood test tracks your metabolic response, liver and kidney function, thyroid health, and inflammation to keep your progress on track.
Your results delivered as a complete pathology report, with reference ranges and clinical context for every marker. Easy to read yourself or hand straight to your GP.
The same pathology report format used by hospitals and GPs across Australia.
Every result is shown alongside the normal range. Abnormal results are highlighted in red so you spot them straight away.
Delivered privately within 24-48 hours of testing. Yours to keep, share or print.
See at a glance which markers are healthy and which need attention.
Calculated free testosterone is below the lower reference limit. May be associated with symptoms of low testosterone including fatigue, low libido, and reduced energy.
Metabolic, cardiovascular, organ, thyroid and inflammation markers measured together. Reveals whether GLP-1 is producing the metabolic improvements you expect AND catches the side effects that need monitoring.
The most accurate way to track GLP-1 efficacy. HOMA-IR should drop significantly within 3-6 months on treatment. If it is not, dose adjustment or alternative approach may be needed. Beyond scale weight, this is the real progress metric.
Weight loss is one signal. HbA1c improvement is the actual metabolic health change. A drop of 0.5-1.0%+ on GLP-1 over 3 months is typical and shows the medication is improving how your body handles blood sugar.
GLP-1 medications carry a black-box warning for medullary thyroid cancer risk. Routine thyroid monitoring on treatment is standard care. TSH, FT3 and FT4 together reveal subclinical thyroid dysfunction the standard TSH check alone would miss.
Weight loss should reduce inflammation. hsCRP catches the low-grade inflammation that drives cardiovascular disease and metabolic dysfunction. Tracking it on GLP-1 reveals whether the metabolic benefits are translating to lower inflammation.
ALT, AST, ALP, GGT, eGFR, creatinine and electrolytes. The organ-stress markers most likely to shift on GLP-1 medication. Regular monitoring catches issues early enough to adjust treatment before harm occurs.
Australia's easiest blood test
One price covers your request form, testing and results. It really is that easy.
Check out and your pathology request form arrives in your inbox straight away. No GP consult or referral needed.
Take your form to any of our 3,300+ partner collection centres across Australia. No appointment, just walk in.
Sent privately to your email, in the original NATA-accredited lab report format. Never linked to Medicare or My Health Record.
Thousands of Aussies trust MediTests to make blood testing fast, easy and stress-free.
Everything you need to know before you order.
Can't find your answer? Email us at info@meditests.com.au and we'll help.
Get your blood test online today. No consult or referral required, with results in 24 to 48 hours. The easiest way to get a blood test in Australia.
Hundreds of Australians have skipped the referral and the waiting, and taken control of their health with MediTests.
The GLP-1 Progress Blood Test is a glp-1 monitoring blood test for people already on a GLP-1 medication who want to track how their body is responding. Regular monitoring helps you and your prescriber see what is improving and keep an eye on the markers worth watching during treatment.
It measures fasting glucose, fasting insulin, HOMA-IR and HbA1c (to track your metabolic response), liver function and kidney function (EUC), a full thyroid panel (TSH, FT3, FT4) and hsCRP for inflammation. Tracking these over time shows how your metabolic health is shifting and helps confirm things are moving in the right direction.
If you are still deciding whether to start, the GLP-1 Readiness Blood Test sets a baseline first. For a more complete picture including nutrients and a full blood count, the GLP-1 Extended Health Review goes wider. You can also create your own blood test.
The GLP-1 Progress Blood Test needs no GP referral and no appointment, so you can get your blood test online and walk into any of 3,300+ collection centres across Australia, with results in 24 to 48 hours. For more on metabolic health, Healthdirect Australia is a useful reference.
Fasting Glucose: Measures blood sugar levels after fasting. Used to track whether glucose control is improving during treatment.
Fasting Insulin: Reflects insulin production at rest. Monitoring changes in fasting insulin during treatment can indicate whether insulin resistance is improving.
HOMA-IR Score: A calculated estimate of insulin resistance derived from fasting glucose and insulin. Useful for tracking metabolic improvement over time.
HbA1c: Reflects average blood glucose over the past two to three months. A key marker for monitoring glucose control during GLP-1 therapy.
Total Cholesterol: A broad measure of cardiovascular risk tracked alongside other lipid markers to assess treatment-related changes.
LDL Cholesterol: The cholesterol fraction most associated with cardiovascular risk. Monitored during treatment to track any lipid changes.
HDL Cholesterol: The protective cholesterol fraction. An increase in HDL during treatment is a positive metabolic indicator.
Triglycerides: Elevated triglycerides are common in people with insulin resistance and often improve with GLP-1 therapy. Tracked to monitor metabolic response.
Non-HDL Cholesterol: A more complete measure of cardiovascular risk than LDL alone, calculated by subtracting HDL from total cholesterol.
Bilirubin: A waste product from red blood cell breakdown. Monitored as part of ongoing liver health assessment during treatment.
Direct Bilirubin: Provides more specific information about liver and bile duct function when total bilirubin is elevated.
ALP (Alkaline Phosphatase): A liver and bone enzyme. Ongoing monitoring detects any treatment-related changes in liver health.
AST (Aspartate Aminotransferase): A marker of liver cell integrity. Assessed alongside ALT to identify any liver stress during treatment.
ALT (Alanine Aminotransferase): One of the most sensitive markers of liver cell damage. Important to monitor during medication use.
GGT (Gamma-Glutamyl Transferase): Sensitive to liver stress and medication effects. Tracked as part of routine liver function monitoring.
Albumin: Produced by the liver and reflects both liver function and nutritional status. Monitored during treatment as appetite changes may affect protein intake.
Globulin: Assessed alongside albumin to characterise liver function and identify inflammatory patterns.
Total Protein: A combined measure of albumin and globulin providing a broad assessment of liver function and nutritional status.
Sodium: An essential electrolyte for fluid balance and blood pressure regulation. Monitored as part of ongoing kidney and metabolic health assessment.
Potassium: Critical for heart rhythm and muscle function. Abnormal levels can have significant cardiac implications.
Chloride: Works alongside sodium to maintain fluid and acid-base balance. Assessed as part of a complete electrolyte profile.
Bicarbonate: Reflects the kidneys’ ability to regulate blood pH. A marker of metabolic and renal health.
Urea: A kidney-filtered waste product. Elevated levels can indicate reduced kidney function or changes in dietary protein intake.
Creatinine: One of the most reliable markers of kidney function. Monitored during treatment to detect any renal changes.
eGFR (Estimated Glomerular Filtration Rate): The best overall indicator of kidney filtration capacity. Tracked to identify any early decline in kidney function.
TSH (Thyroid Stimulating Hormone): The most sensitive indicator of thyroid function. Included given the known interaction between GLP-1 receptors and thyroid tissue. Abnormal TSH can affect metabolism, energy, and weight regulation.
FT4 (Free Thyroxine): The primary hormone produced by the thyroid. Assessed alongside TSH to provide a more complete picture of thyroid function.
FT3 (Free Triiodothyronine): The active form of thyroid hormone with a direct effect on cellular metabolism. Measured alongside FT4 and TSH to assess how well the body is converting thyroid hormones.
High Sensitivity CRP (hsCRP): A sensitive marker of low-grade systemic inflammation. Tracking hsCRP during therapy helps identify whether inflammation is improving in line with metabolic changes or flagging early concerns.
1. Receive your referral instantly after purchase
2. Quick blood test at your local collection centre
3. Results to your inbox within 1-2 days
Unlock coupon
Get 10% off your first blood test
Get updates on our new blood panels and join the community.
Please enter a valid email address.
Unlock coupon
Get 10% off your first at-home test kit
Collected at home, posted back, results to your inbox. No clinic visit needed.
Please enter a valid email address.
